The title compound, C17H20N6O2S, is a bioisoster of torasemide, a loop
diuretic whose structure has been described previously. The sulfonylu
rea chain of torasemide is replaced by a sulfonylcyanoguanidine functi
on. Whereas the torasemide molecule and some sulfonylurea derivatives
exhibit one of the three alpha, beta or gamma conformations, the confo
rmation being assigned according to the torsion angles in the side cha
in, the title compound displays a new delta conformation. This conform
ation is stabilized by two intramolecular N-H ... O hydrogen bonds. A
prototropic form of the title compound corresponding to it zwitterion
[-S-N--C-, N+-H (pyridinium)] is observed {i.e ylphenylamino)-3-pyridi
niosulfonyl]guanidin-3-ide} . The crystal cohesion is the result of bo
th van der Waals interactions and one intermolecular N+-H ... N- hydro
gen bond involving the N atoms of the zwitterion,